Zacks Research Issues Positive Estimate for ALNY Earnings
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) – Stock analysts at Zacks Research upped their Q1 2025 earnings estimates for shares of Alnylam Pharmaceuticals in a research note issued to investors on Thursday, March 6th. Zacks Research analyst A. Chakraborty now expects that the biopharmaceutical company will post earnings per share of ($0.67) for the […]
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) – Stock analysts at Zacks Research upped their Q1 2025 earnings estimates for shares of Alnylam Pharmaceuticals in a research note issued to investors on Thursday, March 6th. Zacks Research analyst A. Chakraborty now expects that the biopharmaceutical company will post earnings per share of ($0.67) for the […]
